Home > Insider Trading > Filing (0001209191-20-027464)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550395	David Altshuler	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Global Research And Cso	No	Yes	No	No

Transaction Summary

Sold:	2,330 shares	Avg. Price: $260.86	Total Value: $607,803.01
Number of Shares After Transactions:	28,902 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-04	2,330	$86.52	31,232	No	4	M	Direct
Common Stock	Disposition	2020-05-04	700	$259.18	30,532	No	4	S	Direct
Common Stock	Disposition	2020-05-04	700	$260.17	29,832	No	4	S	Direct
Common Stock	Disposition	2020-05-04	237	$261.31	29,595	No	4	S	Direct
Common Stock	Disposition	2020-05-04	500	$262.45	29,095	No	4	S	Direct
Common Stock	Disposition	2020-05-04	193	$264.78	28,902	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-04	2,330	$0.00	2,330	$86.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,990		2027-02-02	No	4	M	Direct

Footnotes

Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $259.18 (range $258.74 to $259.63).
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $260.17 (range $259.88 to $260.64).
Open market sales reported on this line occurred at a weighted average price of $261.31 (range $260.88 to $261.56).
Open market sales reported on this line occurred at a weighted average price of $262.45 (range $262.11 to $263.09).
Open market sales reported on this line occurred at a weighted average price of $264.78 (range $264.68 to $264.89).
The option vests in 16 quarterly installments from 02/03/2017.